WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Sees Large Decrease in Short Interest

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 834 shares, a decline of 61.0% from the February 26th total of 2,136 shares. Based on an average daily trading volume, of 3,129 shares, the short-interest ratio is presently 0.3 days.

WuXi AppTec Price Performance

Shares of WuXi AppTec stock opened at $14.35 on Friday. The business has a 50-day moving average price of $14.66 and a 200 day moving average price of $14.08. WuXi AppTec has a fifty-two week low of $5.73 and a fifty-two week high of $16.35.

Analyst Ratings Changes

Separately, The Goldman Sachs Group upgraded shares of WuXi AppTec to a “buy” rating in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, WuXi AppTec presently has a consensus rating of “Buy”.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.